MSKai
Regulatory Status Disclosed
Overview
MSKai is an advanced image identification and post-processing software platform designed for spine imaging, specifically focusing on T2-weighted lumbar spine MRI analysis. It serves as a decision-support tool for qualified medical professionals, including radiologists and neuro/ortho spine surgeons, assisting them in the objective evaluation of previously acquired lumbar spine MRIs. The software facilitates anatomy segmentation, labeling, and precise measurement of spinal features. It then enables the export of quantitative and qualitative results into customizable reports, thereby supporting greater efficiency and consistency in clinical imaging workflows. MSKai is not intended as a diagnostic device and does not provide or recommend medical diagnoses or treatments; instead, it offers clear, repeatable insights for users trained in medical imaging, reinforcing the central role of expert clinical judgment. Users are responsible for confirming preferences, verifying automated measurements, and finalizing reports in accordance with clinical best practices.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- Anatomy segmentation for lumbar spine MRIs
- Labeling of anatomical features
- Quantitative and qualitative measurement of spine features
- Export of customizable reports
- Objective and repeatable spine measurements
- AI-powered analysis of multi-modality imaging
- Pathology classification
- Range threshold alerts
- Decision-support tool for medical professionals
- Supports efficiency and consistency in clinical imaging workflows
Use Cases
- Supporting pre-surgery authorizations for patients
- Assessing the appropriateness of treatment on a post-intervention basis
- Facilitating risk assessment of employee-injury potential for employers
- Improving spinal patient care and surgical outcomes
- Enhancing efficiency and consistency in clinical imaging workflows
- Evaluation of previously acquired T2-weighted lumbar spine MRIs
What Physicians Need to Know
DICOM Support & Standards
MSKai's system allows for manual or automatic upload of patient imaging, which then loads into a standard MRI viewer, implying compatibility with medical imaging data formats.
PACS Integration Method
Patient imaging can be manually or automatically uploaded to the MSKai library. The system presents a complete list of patient-specific imaging series across modalities within this library.
Reading Room Workflow Impact
MSKai is designed as a radiological assist system that provides objective, repeatable spine measurements, supporting greater efficiency and consistency in clinical imaging workflows. It offers anatomical segmentation, labeling, measurement, and the export of quantitative and qualitative results into customizable reports. The software provides pathology classification and range threshold alerts within seconds.
AI Model Architecture (deep learning approach)
MSKai utilizes artificial intelligence and machine learning, specifically a distinctive machine learning algorithm, for the analysis of multi-modality imaging, focusing on anatomical segmentation, measurement, and pathology classification.
Processing Speed (per study)
The software can identify, measure, and classify spinal anatomy and pathologies from a quantitative and qualitative standpoint within seconds.
FDA Clearance Pathway (510k/De Novo)
MSKai has received 510(k) clearance from the U.S. Food and Drug Administration (FDA), authorizing its use by physicians and radiologists for lumbar spine MRI analysis. The FDA determined it is substantially equivalent to legally marketed devices.
Supported Modalities (CT/MRI/X-ray/US)
The software is cleared for the evaluation of previously acquired T2-weighted lumbar spine MRI images.
Sensitivity & Specificity Data
Initial validation for MSKai's Lumbar Spine MRI segmentation and measurement, derived from 413 patient MRI studies, showed measurement accuracy and segmentation accuracy ranging from 76% to 90%, depending on the focus, when compared to ground truth data from six independent medical and biomechanical professionals.
RSNA/ACR Validation
While MSKai has received FDA 510(k) clearance, specific validation by RSNA or ACR for the MSKai product is not explicitly detailed in the provided information. However, both organizations are actively involved in developing frameworks and guidance for AI in radiology.
Physician Tip
MSKai serves as a valuable decision-support tool for lumbar spine MRI analysis, offering rapid, objective, and repeatable measurements and segmentations. Physicians should remember that it is not a diagnostic device and requires their expert review and affirmation of all software-generated measurements and reports. It can significantly streamline pre-surgical authorizations and post-intervention monitoring by providing consistent data.
MSKai's system supports manual or automatic upload of patient imaging into its library, which then presents studies in a standard MRI viewer. While explicit details on direct PACS integration methods are not provided, its functionality suggests it can ingest imaging data, potentially through various mechanisms including direct uploads or interfaces that feed into its system.
Details
| Category | Radiology & Imaging AI, Surgical AI |
| Pricing | Unknown |
| Deployment | Software (details on cloud/on-premise not specified) |
| Compliance | |
| BAA Available | Unknown AI-estimated |
| HIPAA Compliant | Unknown AI-estimated |
| FDA Status |
1 AI-estimated MSKai received 510(k) clearance from the U.S. Food and Drug Administration (FDA) on December 16, 2024 (K240793). The clearance is for its software as an automated radiological image processing software intended for inspecting and evaluating T2-weighted magnetic resonance imaging (MRI) of the lumbar spine. |
| Integrations | |
| EHR | Not specified |
| Specialties | Neurosurgery, Orthopedics, Radiology |
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate MSKai
Press & Coverage
MSKai (Press Release)
MSKai Spine Imaging Software Receives FDA 510(k) Clearance for Clinical Use
MSKai, an advanced image identification and post-processing software platform for spine imaging, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for use by physicians and radiologists for lumbar spine MRI analysis. The software assists qualified medical professionals in evaluating previously acquired T2-weighted lumbar spine MRIs, enabling anatomy segmentation, labeling, measurement, and export of results into customizable reports.
2025-05
AuntMinnie
MSKai gets FDA nod for AI spine imaging software
MSKai has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its technology to analyze lumbar spine MR images, supporting greater efficiency and consistency in clinical imaging workflows. The software is a decision-support tool for users trained in medical imaging and is not a diagnostic device.
2025-05
Diagnostic Imaging
FDA Clears AI Software for Lumbar Spine MRI Analysis
The FDA has granted 510(k) clearance for MSKai software, which provides AI-powered segmentation, labeling, and measurement tools for the assessment of T2-weighted MRIs of the lumbar spine. This software can facilitate pre-surgical authorizations and monitoring of post-intervention treatments.
2025-05
MSKai (Press Release)
MSKai Wins Coveted Best Technology in Spine Award
MSKai announced that it has won the 'Best Technology in Spine Award'. This recognition highlights the company's innovative artificial intelligence-based technology designed to improve spinal patient care and surgical outcomes.
2024-09
MDPI (International Journal of Environmental Research and Public Health)
Applying AI to Safely and Effectively Scale Care to Address Chronic MSK Conditions
This study assesses the impact of scaling care through AI in patient outcomes, engagement, satisfaction, and adverse events for musculoskeletal (MSK) conditions. The research involved a digital care program supported by a machine learning-based tool to assist physical therapists.
2024-07
MedCity News
AI for MSK Will Bend the Healthcare Cost Curve
AI-powered digital MSK care options can reduce wait times and guide patients to appropriate care, addressing the high prevalence and cost of lower back issues. Agentic AI can expand the capacity for conservative care in hospitals and clinics.
2026-06
News-Medical.net
AI system matches diagnostic accuracy while cutting medical costs
A recent study on the ArXiv preprint server compared the diagnostic accuracy and resource expenditure of AI systems with clinicians for complex cases. Microsoft's AI-powered diagnostic system reportedly outperformed experienced doctors in solving challenging medical cases faster, cheaper, and more accurately.
2025-07
ScienceDaily
AI tool can track effectiveness of multiple sclerosis treatments
Researchers have developed a new AI tool, MindGlide, to interpret and assess the effectiveness of multiple sclerosis (MS) treatments by extracting key information from brain MRI scans. This tool can measure damaged areas, highlight subtle changes like brain shrinkage and plaques, and aims to unlock valuable information from millions of untapped brain images.
2025-04
Videos
Product demos, reviews, and walkthroughs for MSKai.
Will They Remember Me? (feat. Mecca)
MAKAI - Topic
Frequently Asked Questions
MSKai, as a healthcare AI, can primarily assist physicians in diagnostics, such as analyzing medical images and patient data for disease detection, and in precision medicine. It also streamlines administrative tasks like clinical documentation and patient triage, aiming to improve efficiency and support clinical decision-making.
MSKai ensures patient data privacy through robust technical, administrative, and contractual safeguards, including access controls, encryption, and continuous monitoring, to comply with HIPAA. For vendors, this typically involves signing Business Associate Agreements (BAAs) and adhering to frameworks like NIST AI Risk Management, while the FDA regulates AI as Software as a Medical Device (SaMD) to ensure safety and effectiveness.
Key limitations include the potential for algorithmic bias due to training data, a lack of generalizability to diverse patient populations, and the 'black-box' nature that can reduce physician trust. Risks also involve over-reliance leading to decreased critical thinking, the generation of plausible but untrue information (hallucinations), and the current inability of AI to convey empathy in patient communication.
Yes, physicians can consider various other proprietary and increasingly competitive open-source AI models that offer similar diagnostic and administrative support functionalities. Non-AI alternatives primarily involve traditional human clinical judgment and established diagnostic methods, with AI often serving as an augmentation rather than a replacement for human expertise.
Healthcare AI pricing often moves away from purely usage-based models towards hybrid structures, combining a base subscription fee with variable components tied to clinically meaningful units like per patient or per test. Tiered pricing, based on the level of regulatory compliance and liability coverage (basic, standard, premium), is also emerging, with overall costs varying significantly based on the solution's complexity and integration needs.
The accuracy of healthcare AI tools like MSKai can exceed 95% in specific areas such as lung cancer detection or retinal disorder screening, depending on rigorous training with large, diverse datasets. Reliability is ensured through continuous refinement, validation processes (internal, external, case-control, cohort studies), and the inclusion of human-in-the-loop review to contextualize and confirm AI-generated insights before clinical decisions are made.
For physicians adopting MSKai, comprehensive training is crucial, covering how the AI tools function, their limitations, and ethical considerations. The American Medical Association (AMA) advocates for formal AI education that includes bias mitigation, evaluation, and safe workflow integration, often delivered through personalized, adaptive learning platforms and clinical simulations.
Suggest an Edit →
| Last Verified: 2026-04-18 | First Added: 2026-04-18